Phibro Animal Health Corporation logo

Phibro Animal Health Corporation (PAHC)

Market Closed
16 Oct, 08:00 PM
NASDAQ (NMS) NASDAQ (NMS)
$
38. 82
+0.84
+2.2117%
$
1.55B Market Cap
35.95 P/E Ratio
0.48% Div Yield
187,000 Volume
1.1 Eps
$ 37.98
Previous Close
Add Transaction
Day Range
37.24 38.94
Year Range
28.25 60.08
Want to track PAHC and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Phibro Animal Health Corporation (PAHC) Q2 2025 Earnings Call Transcript

Phibro Animal Health Corporation (PAHC) Q2 2025 Earnings Call Transcript

Phibro Animal Health Corporation (PAHC) Q2 2025 Earnings Call Transcript

Seekingalpha | 1 year ago
Compared to Estimates, Phibro (PAHC) Q2 Earnings: A Look at Key Metrics

Compared to Estimates, Phibro (PAHC) Q2 Earnings: A Look at Key Metrics

While the top- and bottom-line numbers for Phibro (PAHC) give a sense of how the business performed in the quarter ended December 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Zacks | 1 year ago
Phibro Animal Health (PAHC) Q2 Earnings and Revenues Surpass Estimates

Phibro Animal Health (PAHC) Q2 Earnings and Revenues Surpass Estimates

Phibro Animal Health (PAHC) came out with quarterly earnings of $0.54 per share, beating the Zacks Consensus Estimate of $0.42 per share. This compares to earnings of $0.33 per share a year ago.

Zacks | 1 year ago
Here's Why Phibro Animal Health (PAHC) is a Strong Momentum Stock

Here's Why Phibro Animal Health (PAHC) is a Strong Momentum Stock

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Zacks | 1 year ago
All You Need to Know About Phibro (PAHC) Rating Upgrade to Strong Buy

All You Need to Know About Phibro (PAHC) Rating Upgrade to Strong Buy

Phibro (PAHC) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

Zacks | 1 year ago
Phibro Animal Health (PAHC) Earnings Expected to Grow: Should You Buy?

Phibro Animal Health (PAHC) Earnings Expected to Grow: Should You Buy?

Phibro (PAHC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks | 1 year ago
Here's Why Phibro Animal Health (PAHC) is a Strong Value Stock

Here's Why Phibro Animal Health (PAHC) is a Strong Value Stock

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Zacks | 1 year ago
Phibro (PAHC) is an Incredible Growth Stock: 3 Reasons Why

Phibro (PAHC) is an Incredible Growth Stock: 3 Reasons Why

Phibro (PAHC) possesses solid growth attributes, which could help it handily outperform the market.

Zacks | 1 year ago
PAHC vs. SYK: Which Stock Should Value Investors Buy Now?

PAHC vs. SYK: Which Stock Should Value Investors Buy Now?

Investors interested in stocks from the Medical - Products sector have probably already heard of Phibro Animal Health (PAHC) and Stryker (SYK). But which of these two stocks presents investors with the better value opportunity right now?

Zacks | 1 year ago
Is Phibro Animal Health (PAHC) Stock Undervalued Right Now?

Is Phibro Animal Health (PAHC) Stock Undervalued Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks | 1 year ago
Why Phibro Animal Health (PAHC) is a Top Value Stock for the Long-Term

Why Phibro Animal Health (PAHC) is a Top Value Stock for the Long-Term

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks | 1 year ago
3 Reasons Growth Investors Will Love Phibro (PAHC)

3 Reasons Growth Investors Will Love Phibro (PAHC)

Phibro (PAHC) possesses solid growth attributes, which could help it handily outperform the market.

Zacks | 1 year ago
Loading...
Load More